Skip to content
healthcare.dev

TECENTRIQ

NDC 50242-918, atezolizumab, injection, solution, from Genentech, Inc..

Product NDC
50242-918
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761034
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-918 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATEZOLIZUMAB840 mg/14mL

Pharmacologic classes

Antibodies [CS]; Antibodies, Monoclonal [CS]; Antibodies, Monoclonal, Humanized [CS]; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
50242-918-01502420918011 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) / 14 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6fa682c9-a312-4932-9831-f286908660ee
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-918

Use it

Look up 50242-918 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-918 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-918. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.